ROIV · Roivant Sciences Ltd
The AI's read
Roivant Sciences shared Phase 2 PHocus topline data for mosliciguat in PH-ILD. The company reported meaningful clinical progress and its shares jumped after the announcement.
Roivant shared Phase 2 topline data showing meaningful clinical progress in PH-ILD, and its shares rose sharply on the news.
Roivant Sciences shared Phase 2 PHocus topline data for mosliciguat in PH-ILD. The company reported meaningful clinical progress and its shares jumped after the announcement.
IonQ raised its full-year 2026 revenue outlook after acquiring SkyWater Technology, and its shares gained following that update.
Pharvaris announced statistically significant, clinically meaningful Phase 3 topline results, and its stock jumped after the release.
Bloom Energy will join the S&P 500, and its shares rose after that announcement.
Follow Roivant Sciences Ltd (ROIV) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for ROIV